 |
|
|
| |
Efficacy and Safety of Emtricitabine/Tenofovir
Alafenamide vs Emtricitabine/Tenofovir Disoproxil Fumarate as a Backbone for Treatment of HIV-1 Infection in Virologically Suppressed Adults: Subgroup Analysis by 3rd Agent
|
| |
| |
Reported by Jules Levin
HIV Glasgow 2016 Oct 23-26
Frank Post,1 Yazdan Yazdanpanah,2 Gabriel Schembri,3 Adriano Lazzarin,4 Jacques Reynes,5 Franco Maggiolo,6 Mingjin Yan,7 Michael Abram,7 Cecilia Tran-Muchowski,7 Andrew Cheng,7 Martin Rhee7
1King's College Hospital, London, UK; 2Hôpital Bichat-Claude Bernard, Paris, France; 3The Hathersage Integrated Contraception, Sexual Health and HIV Service, Manchester, UK;
4Ospedale San Raffaele, Milano, Italy; 5Centre Hospitalier Universitaire de Montpellier, France; 6ASST Papa Giovanni XXIII, Bergamo, Italy; 7Gilead Sciences, Inc., Foster City, California, USA
|
| |
|
|
|
|
|
